Xiaoyan Xin
Hebei Medical University(CN)Jilin University(CN)Nantong University(CN)Cangzhou Central Hospital(CN)Zhuhai People's Hospital(CN)Nanjing Drum Tower Hospital(CN)Second People's Hospital of NanTong(CN)Xingtai People's Hospital(CN)First Hospital of Jilin University(CN)Wuhan Union Hospital(CN)Union Hospital(CN)
Publications by Year
Research Areas
Cancer Research and Treatments, RNA modifications and cancer, RNA Interference and Gene Delivery, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Endometriosis Research and Treatment
Most-Cited Works
- → CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis(2016)122 cited
- → Integration of immunogenic activation and immunosuppressive reversion using mitochondrial-respiration-inhibited platelet-mimicking nanoparticles(2019)97 cited
- → The Effects of miR-195-5p/MMP14 on Proliferation and Invasion of Cervical Carcinoma Cells Through TNF Signaling Pathway Based on Bioinformatics Analysis of Microarray Profiling(2018)86 cited
- → Clinical Evaluation of E-cadherin Expression and its Regulation Mechanism in Epithelial Ovarian Cancer(2006)74 cited
- → Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells(2006)72 cited
- → Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease